FMR1 and fragile X syndrome: We propose that utilization of a direct-to-hiDFP protocol to study FXS will provide a more robust mechanism than the current use of hiPSCs by negating concerns regarding the premature inactivation of the FMR1 gene as seen in FXS patient-derived hiPSC lines (Bhattacharyya and Zhao, 2015).